MidCap MFICL Flat at 2540 Consolidation Continues 20260515 BNPP Warns of Overheating Risks After US April Jobs Report Beats Expectations Zymeworks ZYME Jumps 209 on Strong Momentum 20260518 Amicus Therapeutics FOLD Stock Steady at 1449 Support at 1377 20260518 Indian 10Year Bond Yield Crosses 71 Implications for Equities and Debt Strategy Michael Saylor Tokenization May Enable Investors to Shop for Yield Challenging Traditional Banking Keysight Technologies Releases Q2 2026 Earnings Call Summary PutinXi Talks Revive Stalled Russian Gas Pipeline as Iran Conflict Disrupts Energy Markets GM Unveils AllElectric Cadillac Vistiq Targeting 300Mile Range SpaceX Heavy Reliance on Starlink Profitability Seen as IPO Approaches Surging Gas Prices Disproportionately Burden LowerIncome Households New York Fed Study Indicates Oura Health Files Confidentially for IPO Joining Wearable Tech Wave Flipkart Achieves Record SingleDay Sales of 200 Million Marking Ecommerce Milestone GLOBALFOUNDRIES Inc Announces Quantum Technology Solutions Initiative SVCO Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 274 Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise Farmers Merchants Bancorp Inc FMAO Q1 2026 Earnings Earnings Beat Driven by Strong Expense Management and Loan Growth SOBR Safe Inc Q3 2025 Earnings Continued Losses Reflect EarlyStage Operations Diageo DEO Q1 2026 Earnings EPS Misses Estimates as Spirits Demand Softens Globally Theravance Biopharma Inc TBPH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise SRJN Q1 2026 Earnings EPS Beat Driven by Solid Operational Execution Consensus Cloud Solutions Inc CCSI Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Despite Flat Revenue Picture Horizon Bancorp Inc HBNC Q1 2026 Earnings EPS Beats Estimates Despite Modest Share Declines OBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher VNDA Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Under Incoming Chair Warsh FBRX Q1 2026 Earnings Narrower Loss But Clinical Path Remains Uncertain